Your session is about to expire
Xifaxan vs Rifampin
Introduction
For patients dealing with certain gastrointestinal conditions, such as irritable bowel syndrome (IBS) and hepatic encephalopathy, or infectious illnesses like tuberculosis, the choice of antibiotic can be a key factor in managing symptoms. Xifaxan and Rifampin are two such drugs that are prescribed for these conditions. They each operate differently within the body but have similar goals: to eliminate harmful bacteria and reduce discomfort. Xifaxan is a non-absorbable antibiotic specifically targeting gastrointestinal tract infections, which means it primarily works in the gut without being absorbed into your bloodstream. On the other hand, Rifampin is an antibacterial agent that inhibits DNA-dependent RNA polymerase in various bacteria making it effective against a wider range of bacterial infections but comes with more potential side effects due to its systemic absorption.
Xifaxan vs Rifampin Side By Side
| Attribute | Xifaxan | Rifampin |
|---|---|---|
| Brand Name | Xifaxan | Rifampin |
| Contraindications | Severe diarrhea or rash after starting the medication, use of certain antiviral medicines for HIV/AIDS or hepatitis C, liver disease | Use of certain antiviral medicines for HIV/AIDS or hepatitis C, liver disease, use of hormonal contraceptives |
| Cost | Around $2,500 for 60 tablets of 550 mg | Around $50 for 30 capsules of 300 mg |
| Generic Name | Rifaximin | Rifampin |
| Most Serious Side Effect | Signs of an allergic reaction, severe diarrhea with dehydration caused by Clostridium difficile, liver conditions | Signs of an allergic reaction, skin reactions, severe nausea, vomiting, jaundice, dark urine, changes in vision, unusual mood swings or behavioral changes |
| Severe Drug Interactions | Certain antiviral medicines for HIV/AIDS or hepatitis C | Decreased effectiveness of hormonal contraceptives, potential interactions with numerous medications due to induction effect on liver enzymes |
| Typical Dose | 200–400 mg three times a day | 600 mg/day for adults |
What is Xifaxan?
Rifaximin (the generic name for Xifaxan) is an antibiotic that fights bacterial infection only in the intestines. It was first approved by the FDA in 2004 and acts by inhibiting bacterial RNA synthesis, thus killing bacteria directly. Rifaximin is prescribed for various gastrointestinal disorders like travelers' diarrhea caused by E.coli and reduction of hepatic encephalopathy risk. Unlike other antibiotics that can affect a wide range of bacteria throughout your body, rifaximin stays in your gut and impacts only intestinal bacteria.
On the other hand, Rifampin is another antibiotic but it's used to treat or prevent tuberculosis (TB). It was first introduced into clinical practice in 1966. Rifampin works by preventing TB bacteria from making proteins, which causes them to die off over time. Compared to rifaximin, rifampin has more systemic effects on the body and may interact with more medications.
What conditions is Xifaxan approved to treat?
Xifaxan is approved for the treatment of specific infections and conditions, including:
- Traveler's Diarrhea caused by noninvasive strains of Escherichia coli
- Reduction in risk of overt hepatic encephalopathy recurrence
- Irritable Bowel Syndrome with diarrhea (IBS-D) in adults
Rifampin, on the other hand, is used to treat or prevent several types of bacterial infections such as:
- Tuberculosis (TB)
- Legonella pneumophila
- Meningococcal disease
How does Xifaxan help with these illnesses?
Xifaxan is an antibiotic that helps to manage bacterial infections in the intestines by inhibiting the synthesis of bacterial RNA. It accomplishes this by binding to a subunit of bacterial DNA-dependent RNA polymerase, blocking one of the steps in protein synthesis. This prevents bacteria from growing and multiplying, thus controlling their population levels within your gut. Unlike other antibiotics, Xifaxan mostly stays within the gut and doesn't significantly affect other parts of the body.
Rifampin, on the other hand, operates differently than Xifaxan but also acts as an antibacterial agent. It works by inhibiting another part of protein synthesis process; it binds with high affinity to a different subunit of DNA-dependent RNA polymerase which blocks initiation step rather than elongation phase blocked by Xifaxan. Its activity isn’t limited only to intestinal bacteria as rifampin circulates systemically after being absorbed from gastrointestinal tract into bloodstream.
Both medications can control bacterial populations effectively but are used for different types and locations of infections due to their distinct mechanisms and dispersion patterns.
What is Rifampin?
Rifampin, also known as Rifadin among other brand names, is an antibiotic medication used to treat several types of bacterial infections including tuberculosis. It functions by inhibiting the DNA-dependent RNA polymerase in susceptible bacteria, preventing transcription and thus protein synthesis. This mechanism prevents the replication of bacteria leading to their eventual death. The FDA first approved rifampin in 1971.
Unlike Xifaxan which primarily acts in the gut and isn't well absorbed into circulation, rifampin is readily absorbed from the gastrointestinal tract when taken orally and widely distributed throughout body tissues and fluids. A notable characteristic of Rifampin is that it can cause a harmless orange discoloration to urine, sweat or tears.
While its side-effect profile might differ slightly from drugs like Xifaxan due to these differences in absorption and distribution; common side effects are generally mild and include gastrointestinal upset such as nausea or vomiting along with rash or itching.
What conditions is Rifampin approved to treat?
Rifampin is a potent antibiotic that has been approved by the FDA for treating several conditions, including:
- Tuberculosis (TB)
- Leprosy
- Legionnaire's disease It is also used in combination with other medications to eliminate certain bacteria from your nose and throat that may cause meningitis or other infections.
How does Rifampin help with these illnesses?
Rifampin is an antibiotic that functions by inhibiting the RNA synthesis of bacteria, which leads to their eventual death and eradication from the body. Specifically, rifampin binds to the DNA-dependent RNA polymerase of susceptible bacteria, hindering its function and leading to ineffective protein production within bacterial cells. This disruption in bacterial metabolism results in a broad-spectrum antibacterial action against many types of pathogens. While Xifaxan also has antibacterial properties, it mainly works inside the gut without significant absorption into systemic circulation. Conversely, Rifampin is well-absorbed and distributed throughout the body after oral ingestion or intravenous administration. It's often prescribed for treating serious infections such as tuberculosis or methicillin-resistant Staphylococcus aureus (MRSA), where broader systemic action is required compared to localized gastrointestinal treatment provided by drugs like Xifaxan.
How effective are both Xifaxan and Rifampin?
Both rifaximin (Xifaxan) and rifampin have established histories of success in treating different types of bacterial infections, and were initially approved by the FDA several decades ago. Due to their distinct antimicrobial spectra, they may be prescribed under different circumstances. The effectiveness of rifaximin and rifampin was directly studied in numerous clinical trials over the years; both drugs exhibited comparable efficacy in managing symptoms related to their respective indications as well as similar safety profiles.
Rifaximin is a non-systemic antibiotic that works primarily within the gastrointestinal tract making it particularly useful for conditions such as hepatic encephalopathy or irritable bowel syndrome with diarrhea (IBS-D). A 2011 review showed that it is effective at reducing symptoms associated with these disorders starting from the first week of treatment, has fewer systemic side effects compared to many other antibiotics due its minimal absorption into bloodstream, and is generally well-tolerated.
On the other hand, Rifampin is a broad-spectrum antibiotic used predominantly for tuberculosis therapy but also indicated for certain staphylococcal infections including methicillin-resistant Staphylococcus aureus (MRSA). A 2016 meta-analysis demonstrated that Rifampin seems more effective than placebo when combined with another antibiotic agent in eradicating MRSA infection. Yet, use caution while prescribing Rifampin given potential drug-drug interactions owing to its induction effect on liver enzymes responsible for metabolizing numerous medications. Nonetheless due to its established efficacy against mycobacteria including Mycobacterium tuberculosis makes it an optimal choice where such pathogens are implicated.
Related trials for xifaxan and rifampin
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Xifaxan typically prescribed?
Oral dosages of Xifaxan for adults typically range from 200–400 mg three times a day, depending on the condition being treated. For children, dosage is usually determined by their weight and the specific condition being treated. In contrast, Rifampin is commonly prescribed at 600 mg/day for adults and adolescents over 15 years old, while children between the ages of 3 months to 12 years are generally started with doses calculated based on their body weight. Dosage can be adjusted after a few weeks if there isn't an adequate response; however, care should be taken not to exceed maximum recommended daily dose (1200 mg) in any case.
At what dose is Rifampin typically prescribed?
Rifampin treatment is typically initiated at a dosage of 600 mg/day for adults, administered once daily. The dose can then be altered based on the patient's weight and response to therapy. For children, Rifampin is usually given at a dosage of 10-20 mg/kg up to a maximum of 600mg per day, administered once daily. It's essential that this medication be taken on an empty stomach with plenty of water. If there isn't any improvement after several weeks or if side effects become bothersome, you should consult your healthcare provider as they may need to adjust your dose or switch you to another medication.
What are the most common side effects for Xifaxan?
Common side effects of Xifaxan may include:
- Nausea
- Vomiting
- Constipation
- Bloating or gas in your stomach
- Stomach pain
- Feeling like you need to urgently empty your bowel
- Feeling that your bowel is not completely emptied.
On the other hand, Rifampin can cause side effects such as:
- Heartburn,
- Gas,
- Upset stomach,
- Decreased appetite,
- Drowsiness and dizziness.
More serious but less common side effects include flu-like syndrome, changes in skin color (yellowing), easy bruising/bleeding, persistent nausea/vomiting, dark urine and unusual tiredness. As always, seek immediate medical assistance if any of these symptoms occur.
Are there any potential serious side effects for Xifaxan?
While Xifaxan is typically well tolerated, it can still have potential side effects that should be taken into account:
- Signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
- Severe diarrhea with dehydration caused by Clostridium difficile - stomach pain or bloating, watery or bloody diarrhea, feeling very thirsty or hot and unable to urinate
- Liver conditions: upper right-side abdominal discomfort; loss of appetite; dark urine coloration; jaundice (yellowing skin and eyes)
As for Rifampin:
- Symptoms indicating liver problems: nausea/vomiting persisting for more than a few days; tenderness in the upper abdomen area on the right-hand side; abnormal fatigue levels and lack of energy
- Hematologic reactions such as low platelet count characterized by unusual bleeding or bruising
- Hypersensitivity reactions like fever and rash
In both cases if you experience any severe symptoms consult with your healthcare provider immediately.
What are the most common side effects for Rifampin?
Rifampin, in comparison to Xifaxan, can have a distinct side effect profile that includes:
- Nausea, vomiting or stomach upset
- Heartburn or gas
- Loss of appetite leading to weight loss
- Drowsiness or fatigue
- Headache and dizziness
- Muscle weakness or joint pain
- Changes in taste perception
- Visual disturbances such as blurred vision It may also cause more severe effects like confusion and agitation. In rare cases, it might lead to skin rash and changes in urine color (urine turning red-orange). It's essential for patients taking Rifampin to monitor these potential symptoms closely.
Are there any potential serious side effects for Rifampin?
Rifampin, though generally well-tolerated, can lead to some serious side effects. The symptoms that might suggest a more severe reaction to the drug include:
- Signs of an allergic reaction such as hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
- Skin reactions including fever with sore throat and burning eyes - skin pain followed by a red or purple skin rash that spreads (especially in the face or upper body) causing blistering and peeling
- Severe nausea, vomiting
- Jaundice (yellowing of the skin)
- Dark urine
- Changes in vision may occur leading to blurred vision and visual disturbances
- Unusual mood swings or behavioral changes such as confusion could be indicative of underlying neurological impact.
If you experience any of these symptoms while on Rifampin therapy it is vital you stop taking the medication immediately and seek medical attention without delay.
Contraindications for Xifaxan and Rifampin?
Both Xifaxan and Rifampin, like most antibiotics, may cause side effects in some people. If you experience severe diarrhea or develop a rash after starting these medications, seek immediate medical attention.
Neither Xifaxan nor Rifampin should be taken if you are using certain other drugs such as antiviral medicines for HIV/AIDS or hepatitis C. Always inform your healthcare provider about the medication you are currently taking; some of these drugs could interact with either Xifaxan or Rifampin causing harmful effects.
Rifampin is known to decrease the effectiveness of hormonal contraceptives such as birth control pills, patches, rings, injections etc., hence alternate methods of contraception should be considered while using this drug. Similarly, consult your doctor before taking any over-the-counter medicine while on treatment with either Xifaxan or Rifampin to avoid potential drug interactions.
If you have liver disease and are prescribed Xifaxan or if you have a history of liver disease and will take rifampicin then regular monitoring of blood tests will be required due to possible hepatotoxicity associated with these medications.
Finally remember that all antibiotics including both rifaximin (Xiafaxan) and rifampicin (Rifadin), when not properly used can contribute towards antibiotic resistance which is a major global health concern so they must always be taken exactly as directed by your healthcare provider.
How much do Xifaxan and Rifampin cost?
For the brand name versions of these drugs:
- The price of 60 tablets of Xifaxan (550 mg) averages around $2,500 which works out to approximately $83/day for a usual dose.
- The price of 30 capsules Rifampin (300 mg) averages is about $50, working out to approximately $1.67/day.
Thus, if you are on a regular dosage for either drug, then brand-name Rifampin is significantly less expensive on a per-day treatment basis compared to Xifaxan. Please note that cost should not be your primary consideration in determining which of these drugs is right for you.
When it comes to generic versions:
- Generic rifampin costs can vary but are generally lower than the brand-name version with prices ranging from about $0.25-$1 per day depending on the dose and size pack purchased.
- Currently there is no generic equivalent available for Xifaxan in the United States, so patients must pay full price unless their insurance covers part or all of this medication's cost.
Popularity of Xifaxan and Rifampin
Rifaximin, also known by its brand name Xifaxan, and rifampin are both antibiotics but they have different uses and prevalence. In 2020, rifaximin was prescribed to about 1.2 million people in the US for treatment of certain intestinal infections and prevention of hepatic encephalopathy. Rifaximin accounted for around 3% of all antibiotic prescriptions related to gastrointestinal conditions.
By contrast, rifampin has a more traditional role in treating serious bacterial infections such as tuberculosis. This medication was prescribed to approximately 450 thousand Americans in 2020. It accounts for under 1% of overall antibiotic prescriptions due to its specific usage against mycobacterial species like Mycobacterium tuberculosis which cause diseases that are less common than those treated by broader spectrum antibiotics like amoxicillin or ciprofloxacin.
In terms of trends over time, the use of rifaximin has been generally increasing since it gained FDA approval for preventing hepatic encephalopathy back in 2010 while the prescription rate for rifampin has remained relatively steady over recent years given the stable incidence rate of tuberculosis.
Conclusion
Both Xifaxan (rifaximin) and Rifampin have long-standing records of usage in patients with bacterial infections, specifically gastrointestinal issues for Xifaxan and tuberculosis for Rifampin. Their efficacy is supported by numerous clinical studies indicating that they are more effective than placebo treatments. While both drugs can be used concurrently under certain circumstances like resistant strains of bacteria or complex cases, the decision to combine these medications should be done judiciously by a physician due to their different mechanisms of action.
Xifaxan works primarily on the gut flora without significant absorption into the systemic circulation, making it ideal for conditions such as travelers' diarrhea or hepatic encephalopathy. On the other hand, rifampin is absorbed systemically and acts on various bacteria throughout the body, making it suitable as a first-line treatment option for tuberculosis.
Both drugs are available in generic form which represents significant cost savings especially if paying out-of-pocket. It's worth noting that noticeable effects may not occur immediately after starting either medication; an adjustment period may be necessary.
The side effect profile between these two antibiotics differs somewhat: while both are generally well-tolerated, rifampin frequently causes discoloration of bodily fluids (such as urine turning orange-red), whereas this does not occur with Xifaxan. Regardless of which drug is being taken, all patients must monitor their symptoms closely when starting treatment and seek medical help immediately if they notice any worsening condition or severe side effects.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Gillis, J. C., & Brogden, R. N. (1995, March). Rifaximin. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-199549030-00009
- Menees, S. B., Maneerattannaporn, M., Kim, H. M., & Chey, W. D. (2012, January). The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1038/ajg.2011.355
- Harris, L. A., & Baffy, N. (2017, October 13). Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome. Postgraduate Medicine. Informa UK Limited.http://doi.org/10.1080/00325481.2017.1383819
- Garcia-Prats, A. J., Svensson, E. M., Winckler, J., Draper, H. R., Fairlie, L., van der Laan, L. E., … Hesseling, A. C. (2021, September 16). Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial. Journal of Antimicrobial Chemotherapy. Oxford University Press (OUP).http://doi.org/10.1093/jac/dkab336
- Gerard, L., Garey, K. W., & DuPont, H. L. (2005, April). Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections. Expert Review of Anti-infective Therapy. Informa UK Limited.http://doi.org/10.1586/14787210.3.2.201
- Lawrence, K. R., & Klee, J. A. (2008, August). Rifaximin for the Treatment of Hepatic Encephalopathy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. Wiley.http://doi.org/10.1592/phco.28.8.1019
- Palma-Aguirre, J. A., Absalón-Reyes, J. A., Novoa-Heckel, G., de Lago, A., Oliva, I., Rodríguez, Z., … Namur, S. (2007, June). Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: Two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Clinical Therapeutics. Elsevier BV.http://doi.org/10.1016/j.clinthera.2007.06.007
- Luzzati, R., Giacomazzi, D., Franchi, F., Barcobello, M., & Vento, S. (2007, August). Life-threatening, Multiple Hypersensitivity Reactions Induced by Rifampicin in One Patient with Pulmonary Tuberculosis. Southern Medical Journal. Southern Medical Association.http://doi.org/10.1097/smj.0b013e3180f60a57
- Adachi, J. A., & DuPont, H. L. (2006, February 15). Rifaximin: A Novel Nonabsorbed Rifamycin for Gastrointestinal Disorders. Clinical Infectious Diseases. Oxford University Press (OUP).http://doi.org/10.1086/499950